131 related articles for article (PubMed ID: 10423536)
1. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.
Nunoya K; Yokoi T; Takahashi Y; Kimura K; Kinoshita M; Kamataki T
J Biochem; 1999 Aug; 126(2):402-7. PubMed ID: 10423536
[TBL] [Abstract][Full Text] [Related]
2. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
Fernandez-Salguero P; Hoffman SM; Cholerton S; Mohrenweiser H; Raunio H; Rautio A; Pelkonen O; Huang JD; Evans WE; Idle JR
Am J Hum Genet; 1995 Sep; 57(3):651-60. PubMed ID: 7668294
[TBL] [Abstract][Full Text] [Related]
3. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
Oscarson M; McLellan RA; Gullstén H; Agúndez JA; Benítez J; Rautio A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Oct; 460(2):321-7. PubMed ID: 10544257
[TBL] [Abstract][Full Text] [Related]
5. A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.
Nunoya KI; Yokoi T; Kimura K; Kainuma T; Satoh K; Kinoshita M; Kamataki T
J Pharmacol Exp Ther; 1999 Apr; 289(1):437-42. PubMed ID: 10087035
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
Oscarson M; McLellan RA; Asp V; Ledesma M; Bernal Ruiz ML; Sinues B; Rautio A; Ingelman-Sundberg M
Hum Mutat; 2002 Oct; 20(4):275-83. PubMed ID: 12325023
[TBL] [Abstract][Full Text] [Related]
7. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Nunoya K; Yokoi T; Kimura K; Inoue K; Kodama T; Funayama M; Nagashima K; Funae Y; Green C; Kinoshita M; Kamataki T
Pharmacogenetics; 1998 Jun; 8(3):239-49. PubMed ID: 9682269
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.
Ariyoshi N; Takahashi Y; Miyamoto M; Umetsu Y; Daigo S; Tateishi T; Kobayashi S; Mizorogi Y; Loriot MA; Stücker I; Beaune P; Kinoshita M; Kamataki T
Pharmacogenetics; 2000 Nov; 10(8):687-93. PubMed ID: 11186131
[TBL] [Abstract][Full Text] [Related]
9. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population.
Oscarson M; McLellan RA; Gullstén H; Yue QY; Lang MA; Bernal ML; Sinues B; Hirvonen A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Apr; 448(1):105-10. PubMed ID: 10217419
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.
Chen GF; Tang YM; Green B; Lin DX; Guengerich FP; Daly AK; Caporaso NE; Kadlubar FF
Pharmacogenetics; 1999 Jun; 9(3):327-32. PubMed ID: 10471064
[TBL] [Abstract][Full Text] [Related]
11. Expression and alternative splicing of the cytochrome P-450 CYP2A7.
Ding S; Lake BG; Friedberg T; Wolf CR
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):161-6. PubMed ID: 7864805
[TBL] [Abstract][Full Text] [Related]
12. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.
Wang J; Pitarque M; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Feb; 340(2):491-7. PubMed ID: 16378601
[TBL] [Abstract][Full Text] [Related]
13. The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP.
Kitagawa K; Kunugita N; Katoh T; Yang M; Kawamoto T
Biochem Biophys Res Commun; 1999 Aug; 262(1):146-51. PubMed ID: 10448083
[TBL] [Abstract][Full Text] [Related]
14. Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.
Aida K; Moore R; Negishi M
Genomics; 1994 Feb; 19(3):564-6. PubMed ID: 8188299
[TBL] [Abstract][Full Text] [Related]
15. Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.
Zabetian CP; Gelernter J; Cubells JF
Am J Med Genet; 2000 Oct; 96(5):638-45. PubMed ID: 11054771
[TBL] [Abstract][Full Text] [Related]
16. Identification of deletion-junction site of CYP2A6*4B allele lacking entire coding region of CYP2A6 in Japanese.
Ariyoshi N; Sekine H; Nakayama K; Saito K; Miyamoto A; Kamataki T
Pharmacogenetics; 2004 Oct; 14(10):701-5. PubMed ID: 15454735
[No Abstract] [Full Text] [Related]
17. Determination of coumarin metabolism in Turkish population.
Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
[TBL] [Abstract][Full Text] [Related]
18. Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Haberl M; Anwald B; Klein K; Weil R; Fuss C; Gepdiremen A; Zanger UM; Meyer UA; Wojnowski L
Pharmacogenet Genomics; 2005 Sep; 15(9):609-24. PubMed ID: 16041240
[TBL] [Abstract][Full Text] [Related]
19. Novel human CYP2A6 alleles confound gene deletion analysis.
Nakajima M; Yoshida R; Fukami T; McLeod HL; Yokoi T
FEBS Lett; 2004 Jul; 569(1-3):75-81. PubMed ID: 15225612
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
Paschke T; Riefler M; Schuler-Metz A; Wolz L; Scherer G; McBride CM; Bepler G
Toxicology; 2001 Nov; 168(3):259-68. PubMed ID: 11684323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
